ibandronate sodium
- Product NDC
- 25021-827
- 11-digit product format
- 250210827
- Labeler code
- 25021
- Product ID
- 25021-827_f417242c-cc22-450f-83ff-8563f2b03d50
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ibandronate sodium
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA202235
- Marketing category
- ANDA
- Marketing start
- 2014-09-02
- Marketing end
- 0000-00-00
- Substance
- IBANDRONATE SODIUM
- Active strength
- 3 mg/3mL
- Pharmacologic classes
- Bisphosphonate [EPC],Diphosphonates [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-827-61 | 25021082761 | 1 SYRINGE in 1 CARTON (25021-827-61) > 3 mL in 1 SYRINGE | 1 syringe | 2014-09-02 | 0000-00-00 | No | No | Current |